Group Leader, AOC Platform for Extrahepatic Delivery

A*STAR - Agency for Science, Technology and Research; Singapore; On-site; SGD 100,000 - 140,000; Full time

Benefits offered by this job

Competitive Compensation

Long-term Career Growth Opportunities

Job summary

A*STAR - Agency for Science, Technology and Research in Singapore is seeking a Group Leader to develop antibody-oligonucleotide conjugates for extra-hepatic delivery. As a key role in enhancing RNA-based therapeutics, the successful candidate will lead an interdisciplinary team, oversee scientific strategies, and manage project milestones. Required qualifications include a doctorate in a relevant field and extensive experience in antibody discovery and engineering. Competitive compensation and long-term growth opportunities are provided in Singapore's thriving biomedical innovation landscape.

Qualifications

• A minimum of +8 (Senior Scientist) or +12 (Principal Scientist) years of relevant experience.
• Demonstrated track record in antibody discovery and bioconjugation.
• Hands-on experience with conjugation design and analytical characterisation.

Responsibilities

• Lead an interdisciplinary team developing antibody-oligonucleotide conjugates.
• Define AOC design principles for extra-hepatic delivery.
• Drive program strategy and milestones for AOC development.

Skills

Scientific Leadership

Antibody Discovery

Bioconjugation Chemistry

Project Management

Cross-Functional Collaboration

Education

Doctorate degree in Protein Engineering or related field

Tools

Flow Cytometry

LC-MS

SEC

NGS

Job description

A*STAR - Agency for Science, Technology and Research in Singapore is seeking a Group Leader to develop antibody-oligonucleotide conjugates for extra-hepatic delivery. As a key role in enhancing RNA-based therapeutics, the successful candidate will lead an interdisciplinary team, oversee scientific strategies, and manage project milestones. Required qualifications include a doctorate in a relevant field and extensive experience in antibody discovery and engineering. Competitive compensation and long-term growth opportunities are provided in Singapore's thriving biomedical innovation landscape.